ASGCT presentation demonstrates lipid nanoparticle (LNP) mediated delivery to the eye in the context of editing of the ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that data from the Phase 2 study of ...

CTX340 is designed to inhibit production of hepatic angiotensinogen (AGT), a validated target to modulate the renin-angiotensin-aldosterone system (RAAS) and normalize blood pressure durably with a ...

Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German ...

Q1 2024 Earnings Call Transcript May 7, 2024 Ionis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

Ionis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which was narrower than the Zacks Consensus Estimate of a loss of $1.10 per share. The bottom line includes ...

Cycle Pharmaceuticals Limited (Cycle) is proud to announce the launch of ORMALVI™ (dichlorphenamide) tablets, as a treatment option for patients with hyperkalemic periodic paralysis (HyperPP), ...

Cycle Pharmaceuticals Limited (Cycle) is proud to announce the launch of ORMALVItm (dichlorphenamide) tablets, as a treatment option for patients with hyperkalemic periodic paralysis (HyperPP), ...

The company is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded in September 2007 and is headquartered ...

CAMBRIDGE, Mass., May 08, 2024--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for ...

Global Organoids and Spheroids Market was valued at US$ 771.4 million in 2022 and is projected to attain a valuation of US$ 4,567.0 Million by 2031 at a CAGR of 22.42% During the Forecast Period ...

Fatty liver is also called hepatic steatosis and occurs when excessive fat builds in the liver.  Here are some detox drinks to cure the condition. Amla Juice: It is high in antioxidants, ...